Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Dysplastic Nevus Syndrome, Hereditary

fluorodeoxyglucose f18 has been researched along with Dysplastic Nevus Syndrome, Hereditary in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (42.86)24.3611
2020's16 (57.14)2.80

Authors

AuthorsStudies
Andersen, JAS; Bastholt, L; Gerke, O; Grupe, P; Hess, S; Hildebrandt, MG; Holdgaard, PC; Spatzek, AD; Vilstrup, MH1
Antke, C; Emil, N; Giesel, FL; Lawal, I; Mokoala, K; Sathekge, M1
Aalbersberg, EA; Blankenstein, SA; Haanen, JB; Klop, WMC; Stokkel, MPM; van Akkooi, ACJ; van de Wiel, BA; van der Hiel, B; Wondergem, M1
Abouzian, S; Camacho, V; Carrió, I; Duch, J; Estorch, M; Fernández-León, A; Flotats, A; López-Mora, DA; Sabaté-Llobera, A; Sampedro, F; Sizova, M; Stefaneli, P1
Arnold, A; Hohmann, J; Weber, P1
Bastholt, L; Bidstrup, PE; Bojesen, S; Chakera, AH; Ellebæk, E; Helvind, NM; Hendel, HW; Hölmich, LR; Johansen, C; Kjærskov, MW; Petersen, SK; Skyum, H; Svane, IM; Weitemeyer, MB1
Ding, H; Fan, D; Huang, Z; Liu, Y; Wan, Z1
Abernethy-Leinwand, A; Bouchard, DM; Collichio, FA; Ezzell, JA; Giglio, BC; Googe, PB; Ivanova, A; Ivanovic, M; Kowalski, MH; Lee, YZ; Li, Z; Long, PK; Meyers, MO; Moschos, SJ; Nikolaishvili-Feinberg, N; Oldan, JD; Ollila, DW; Smith, E; Thomas, NE; Trembath, DG; Wallack, DE; Wong, TZ; Zhao, W1
Chen, Y; Wu, Y; Zeng, Q; Zhang, F; Zhang, X; Zhou, J1
Chen, KC; Chiu, YJ; Chu, PY; Li, CY; Wang, TH1
Albano, D; Alongi, P; Familiari, D; Fornito, MC; Galia, M; Ganduscio, G; Grassedonio, E; Laudicella, R; Messina, M; Midiri, M; Ruggeri, A; Scalisi, S; Spada, M1
Baldari, S; Baratto, L; Iagaru, A; Laudicella, R; Minutoli, F1
Bhargava, P; Flynt, L; Marcal, L1
Baynosa, J; Cheng, D; De Guzman, MD; Doyle, GM; Jones, MS; Kirgan, D; McNicoll, CF; Rivera, MR; St Hill, CR1
Álamo-de-la-Gala, MDC; Calvo-Morón, MC; García-Gómez, FJ; León-Asuero-Moreno, I; Ríos-Martín, JJ1
Been, LB; Brabander, T; Grünhagen, DJ; Lemstra, C; Mooyaart, AL; Mulder, EEAP; Stahlie, EHA; van Akkooi, ACJ; van der Veldt, AAM; Vegt, E; Verburg, FA; Verhoef, C; Verver, D1
Arsenault, F; Plouznikoff, N1
Alharbi, AA; Aljared, A; Huellner, MW1
Been, LB; Faut, M; Hoekstra, HJ; Kruijff, S; van Ginkel, RJ; van Leeuwen, BL1
Fujii, T; Hishizawa, M; Inagaki, N; Kawaguchi-Sakita, N; Kim, YH; Kitamura, M; Kitawaki, T; Matsumoto, S; Nomura, M; Otsuka, A; Saito, R; Sakamori, Y; Sone, M; Taura, D; Yamasaki, T; Yamauchi, I; Yasoda, A1
Abgral, R; Alavi, Z; Amrane, K; Delcroix, O; Gouva, S; Keromnes, N; Le Goupil, D; Quere, G; Querellou, S; Salaun, PY; Schick, U1
Bastiaannet, E; Bonenkamp, JJ; Hoekstra, HJ; Hoekstra, OS; Koelemij, R; Niebling, MG1
Adams-Huet, B; Anderson, J; Lazaga, FJ; Mathews, D; Oz, OK1
Bagaria, SP; Etzioni, D; Gray, RJ; Haddad, D; Pockaj, BA; Wasif, N1
Fotos, JS; Sogge, SM; Tulchinsky, M1
Eigentler, TK; Garbe, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Schüle, SC1
Ahn, BC; Jeong, SY; Kang, SM; Lee, J; Lee, SJ; Lee, SW; Son, SH1
Giordano, S; Kemppainen, J; Koskivuo, I; Minn, H; Seppänen, M; Veräjänkorva, E; Vihinen, P1

Reviews

2 review(s) available for fluorodeoxyglucose f18 and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
CT and PET/CT findings of primary pulmonary malignant melanoma: a case report and literature review.
    The Journal of international medical research, 2023, Volume: 51, Issue:6

    Topics: Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed

2023
Malignant Cutaneous Melanoma: Updates in PET Imaging.
    Current radiopharmaceuticals, 2020, Volume: 13, Issue:1

    Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Melanoma, Cutaneous Malignant; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed

2020

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Young Adult

2016

Other Studies

25 other study(ies) available for fluorodeoxyglucose f18 and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:7

    Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms

2022
[
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:7

    Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Quinolines; Skin Neoplasms

2022
18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence?
    Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7

    Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase Kinases; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Skin Neoplasms

2022
Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy.
    Melanoma research, 2022, 10-01, Volume: 32, Issue:5

    Topics: Brain; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms

2022
Comparison of 18F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma.
    Medicine, 2022, Oct-21, Volume: 101, Issue:42

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Polyesters; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Suppuration

2022
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
    Annals of surgical oncology, 2023, Volume: 30, Issue:4

    Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms

2023
Malignant Melanoma of the External Auditory Canal on 68 Ga-FAPI PET/CT.
    Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6

    Topics: Ear Canal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms

2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.
    Oncoimmunology, 2023, Volume: 12, Issue:1

    Topics: Fluorodeoxyglucose F18; Glucose; Humans; Kynurenine; Melanoma; Melanoma, Cutaneous Malignant; Prospective Studies; Tryptophan

2023
Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
    Journal of the Chinese Medical Association : JCMA, 2023, 11-01, Volume: 86, Issue:11

    Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms

2023
Clinical and Prognostic Value of
    Current radiopharmaceuticals, 2020, Volume: 13, Issue:1

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms

2020
Nivolumab-Induced Subcutaneous Fat Necrosis: Another FDG-Avid Immune-Related Adverse Event.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:2

    Topics: Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Subcutaneous Fat

2020
The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
    American journal of surgery, 2021, Volume: 221, Issue:4

    Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms

2021
Thyroid Metastasis From Cutaneous Melanoma on an 18F-FDG PET/CT Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:12

    Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Neoplasms

2020
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
    Journal of surgical oncology, 2021, Volume: 124, Issue:7

    Topics: Aged; Antineoplastic Agents, Immunological; Biological Products; Cohort Studies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Herpesvirus 1, Human; Humans; Lymph Nodes; Male; Melanoma; Melanoma, Cutaneous Malignant; Oncolytic Virotherapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms

2021
Clinical relevance of 18F-FDG PET/CT lower-limb imaging in patients with malignant cutaneous melanoma.
    Nuclear medicine communications, 2017, Volume: 38, Issue:12

    Topics: Female; Fluorodeoxyglucose F18; Humans; Lower Extremity; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms; Thigh

2017
BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET/CT in Patients With Malignant Melanoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:5

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms

2018
Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2018, Volume: 44, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms

2018
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Analysis; Thyroid Gland; Thyroiditis; Thyrotropin; Thyroxine; Triiodothyronine

2019
Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma.
    Medicine, 2019, Volume: 98, Issue:29

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Protocols; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Nivolumab; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, X-Ray Computed

2019
Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
    Annals of surgical oncology, 2013, Volume: 20, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult

2013
Comparison of whole-body versus limited whole-body 18F-FDG PET/CT scan in malignant cutaneous melanoma.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult

2013
Staging studies for cutaneous melanoma in the United States: a population-based analysis.
    Annals of surgical oncology, 2015, Volume: 22, Issue:4

    Topics: Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; SEER Program; Skin Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; United States

2015
Bacillus Calmette-Guerin injections for melanoma immunotherapy: potential for a false-positive PET/CT.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:4

    Topics: Aged, 80 and over; BCG Vaccine; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed

2015
Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3

    Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2016
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Probability; Recurrence; Retrospective Studies; ROC Curve; Skin Neoplasms; Tumor Burden

2016